丽珠医药集团股份有限公司（股票代码：01513）于2026年4月1日发布截至2026年3月31日的股份变动月报表，报告期内公司股本结构保持稳定，未有新增发行、购回或注销记录。
公告显示，截至3月末，公司注册股本总额为人民币887,907,171元。其中，H股数量为299,807,117股，A股数量为588,100,054股，均与上月底持平。此外，报告期内未发生任何期权、股权激励及可换股债券等变动事项。
综合本次月报情况，公司股本规模维持不变。公司同时确认遵守香港联交所《上市规则》及相关法律监管要求。公告由公司秘书刘宁签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.